Re: clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies: M. Gelbard, I. Goldstein, W. J. Hellstrom, C. G. McMahon, T. Smith, J. Tursi, N. Jones, G. J. Kaufman and C. C. Carson, III J Urol 2013; 190: 199-207.
Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
S
S
Jain
Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: ravismi2003@yahoo.com.
R M
RM
Mavuduru
Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
M M
MM
Agarwal
Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
S K
SK
Singh
Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
A K
AK
Mandal
D047009:Hathewaya histolytica / Q000201:enzymology*; D006801:Humans; D008297:Male; D003012:Microbial Collagenase / Q000008:administration & dosage*; D010411:Penile Induration / Q000188:drug therapy*
D003012:Microbial Collagenase